Regulatory PathRegulatory requirements compared

Active substance

Technetium tc 99m sestamibi kit

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
CARDIOLITEN/Ainjectable · injectionSHINEPrescription21 Dec 1990
TECHNETIUM TC 99M SESTAMIBIN/Ainjectable · injectionCURIUMPrescription22 Sep 2008
TECHNETIUM TC 99M SESTAMIBIN/Ainjectable · injectionCARDINAL HEALTH 414Prescription28 Apr 2009
TECHNETIUM TC 99M SESTAMIBIN/Ainjectable · injectionJUBILANT DRAXIMAGEPrescription29 Apr 2009
MIRALUMAN/Ainjectable · injectionSHINEDiscontinued21 Dec 1990
TECHNETIUM TC 99M SESTAMIBI10-30mCiinjectable · injectionSUN PHARM INDS INCDiscontinued10 Jul 2009

Safety signals and safety-related labeling changes

All safety entries for technetium tc 99m sestamibi kit →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.